Detalhe da pesquisa
1.
A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data.
Genome Res;
34(1): 94-105, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38195207
2.
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
N Engl J Med;
389(1): 33-44, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37407001
3.
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib.
Blood;
2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38754046
4.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Blood;
143(16): 1616-1627, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38215395
5.
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial.
Blood;
142(8): 687-699, 2023 08 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37390310
6.
Ventricular arrhythmias and sudden death events following acalabrutinib initiation.
Blood;
140(20): 2142-2145, 2022 11 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35917449
7.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024.
J Natl Compr Canc Netw;
22(3): 175-204, 2024 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38626800
8.
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.
Am J Hematol;
99(4): 780-784, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38357757
9.
Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia.
J Immunol;
209(6): 1212-1223, 2022 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35995507
10.
Acalabrutinib in treatment-naive chronic lymphocytic leukemia.
Blood;
137(24): 3327-3338, 2021 06 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33786588
11.
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib.
Blood;
138(23): 2372-2382, 2021 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34314481
12.
Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
Hematol Oncol;
41(4): 771-775, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37010242
13.
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
Am J Hematol;
98(1): 56-65, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36216791
14.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet;
397(10277): 892-901, 2021 03 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33676628
15.
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results.
Blood;
135(15): 1204-1213, 2020 04 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31876911
16.
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022.
J Natl Compr Canc Netw;
20(6): 622-634, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35714675
17.
Management of relapsed/refractory Chronic Lymphocytic Leukemia.
Am J Hematol;
97 Suppl 2: S11-S18, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36125037
18.
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Lancet;
395(10232): 1278-1291, 2020 04 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32305093
19.
Time-Limited Initial Therapy for Young, Fit Patients with CLL.
N Engl J Med;
388(19): 1812-1813, 2023 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37163628
20.
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
N Engl J Med;
379(26): 2517-2528, 2018 12 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30501481